Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells

Abelson murine leukemia viral oncogene homolog (ABL) tyrosine kinase inhibitors (TKIs) have been shown to be effective for treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia patients. However, resistance to ABL TKIs can develop as a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Okabe, Seiichi, Tauchi, Tetsuzo, Tanaka, Yuko, Ohyashiki, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126699/
https://www.ncbi.nlm.nih.gov/pubmed/30197758
http://dx.doi.org/10.18632/oncotarget.25985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126699/
https://www.ncbi.nlm.nih.gov/pubmed/30197758
http://dx.doi.org/10.18632/oncotarget.25985

Ejemplares similares